Podcasts

OncLive On Air^® is a podcast from OncLive^® that provides oncology professionals with the resources and information they need to provide the best patient care. Segments cover every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. New episodes with exclusive interviews with leading oncology experts are released on Mondays and Thursdays.

Talking Tumors: MSK Faculty Highlight Ovarian Cancer Cases

April 25th 2019

Mario M. Leitao Jr, MD, FACOG, FACS, and Dmitriy Zamarin, MD, PhD, of Memorial Sloan Kettering Cancer Center, discuss two common clinical scenarios faced in practice, and the data to support their approaches.

Getting Educated On Advances Made With GI Cancers in Houston

April 19th 2019

We traveled to Houston, Texas, for a State of the Science Summit™ on Gastrointestinal Cancer, which focused on the rapidly evolving landscapes of colorectal cancer, gastric/GEJ cancer, pancreatic cancer, neuroendocrine tumors, and hepatocellular carcinoma.

Highlighting Breakthroughs in Breast Cancer in Nashville

April 10th 2019

We traveled to Nashville, Tennessee, for a State of the Science Summit™ on Breast Cancer, which focused on some of the practice-changing updates that have been occurring in the field.

Spotlight on Clinical Scenarios in GEJ Cancer

April 3rd 2019

In keeping up with the rapidly changing landscape of gastroesophageal junction cancer, we sat down with Joseph Chao, MD, to discuss a clinical scenario he faced in practice, and how he used the latest data available to inform his treatment for his patient.

Gaining Insight Into Progress Made With Genitourinary Cancers in Pasadena

March 28th 2019

We traveled to Pasadena, California, for a State of the Science Summit™ on Genitourinary Malignancies, which focused on the rapidly evolving landscapes of kidney, bladder, and prostate cancer.

Navigating New Advances in Breast Cancer in NYC

March 20th 2019

We traveled to NewYork City, New York, for a State of the Science Summit™ on Breast Cancer, which focused on the latest updates in the rapidly evolving paradigms of triple-negative breast cancer, HER2-positive breast cancer, hormone receptor-positive, HER2-negative disease, and more.

Spotlight on Clinical Scenarios in Rectal Adenocarcinoma

March 16th 2019

We sat down with Marwan Fakih, MD, a professor in the Department of Medical Oncology and Therapeutics Research, associate director for Clinical Investigations at the Comprehensive Cancer Center, to discuss a clinical scenario he faced in practice, and how he used the latest data available to inform his treatment for his patient.

Observing the Latest Advances in Ovarian Cancer in Boston

March 7th 2019

We traveled to Boston, Massachusetts, for a State of the Science Summit™ on Ovarian Cancer and Soft Tissue Sarcoma, which focused on the facets of genetic testing in ovarian cancer, surgical options available for patients with newly diagnosed disease, and emerging strategies for the treatment of patients with uterine sarcomas, among other key topics.

Learning More About Lung Cancer in Kansas City

February 27th 2019

We traveled to Kansas City, Missouri, for a State of the Science Summit™ on Advanced Non–Small Cell Lung Cancer, which focused on recent progress made in squamous NSCLC and small cell lung cancer, provided tips on how to navigate the complex paradigm of oncogene-driven disease, and shed light on emerging biomarkers in the space.

Getting Up to Speed with Progress Made in GU Cancers in Memphis

February 20th 2019

We traveled to Memphis, Tennessee for a State of the Science Summit™ on Genitourinary Cancers, which focused on advances made in the treatment landscapes of metastatic renal cell carcinoma and prostate cancer.

Highlighting Headway Made in NSCLC in New York

February 13th 2019

We traveled to New York, New York, for a State of the Science Summit™ on Advanced Non–Small Cell Lung Cancer, which focused on topics ranging from surgical techniques, to headway made in immunotherapy, to emerging biomarkers, to diagnostic advancements.

Examining Breakthroughs Made in Breast Cancer in Minneapolis

February 7th 2019

We traveled to Minneapolis, Minnesota, for a State of the Science Summit on Breast Cancer, which focused on surgical approaches for node-positive breast cancer, the use of CDK4/6 inhibitors in hormone receptor–positive disease, and emerging drug therapies in triple-negative disease.

Navigating New Advances Made in NSCLC in New York

January 31st 2019

We traveled to Syracuse, New York, for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer, which focused on practice-change clinical trials in the space, as well as novel approaches to treatment with checkpoint inhibitors, targeted therapies, radiation, and minimally invasive surgery.

Making Moves in Multiple Myeloma in NYC

January 24th 2019

We traveled to New York City, New York, for a State of the Science Summit on Multiple Myeloma, which focused on stem cell transplant, minimal residual disease, maintenance options, and treatment approaches for newly diagnosed myeloma.

Perusing Progress Made in NSCLC in Washington DC

January 16th 2019

We traveled to Washington D.C. for a State of the Science Summit on Breast Cancer, which focused on additional recent advances in the NSCLC and small cell lung cancer paradigms, touching on TKIs, immunotherapy, and other investigational agents.

Talking Treatment Strategies for Breast Cancer in Pittsburgh

January 10th 2019

We traveled to Pittsburgh, Pennsylvania for a State of the Science Summit on Breast Cancer, which focused on novel approaches in metastatic triple-negative breast cancer and treatment strategies for patients with brain metastases.

Snapshot of the 2018 ASH Annual Meeting in San Diego

January 4th 2019

We traveled to San Diego, California, for the 2018 ASH Annual Meeting, where we spoke with several experts across hematologic malignancies, including mantle cell lymphoma, chronic lymphocytic leukemia, and multiple myeloma.

Buzzing With News From the San Antonio Breast Cancer Symposium

December 26th 2018

We headed to San Antonio, Texas, for the San Antonio Breast Cancer Symposium, where we spoke to several principal investigators who detailed new applications of novel therapies, surgical intervention strategies, and lifestyle modifications.

Exploring Strides Made in Ovarian Cancer & STS in Stanford

December 20th 2018

We headed to Stanford, California, for a State of the Science Summit on Ovarian Cancer and Soft Tissue Sarcoma, which focused on recent advances made in the treatment landscapes.

Reflecting on New Advances Made in NSCLC in Chicago

December 5th 2018

We headed to Chicago, Illinois, for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer, which focused on recent updates in the field, particularly data from the 2018 World Conference on Lung Cancer.